Conversations with B2B leaders who challenge conventional thinking, share what they have learned, and help life science sales and marketing teams better understand how buyers actually buy.
Trailblazers shares conversations with B2B thought leaders who are innovative, thought-provoking, and willing to challenge conventional thinking.
Hosted by Perry Rearick, the series features leaders, marketers, sales professionals, founders, and industry experts who share what they have learned while building companies, leading teams, serving buyers, and navigating change.
Hear from leaders who are seeing market change firsthand.
Understand how buyers, teams, and companies are adapting.
Challenge familiar assumptions about marketing, sales, and growth.
Use the perspective to show up with more relevance and value.
Jerry Jiang, Vice President of Global Sales at CellBri, joins the Trailblazers to discuss how automation can help make cell therapies less expensive and more accessible. He shares how CellBri is working to automate cell therapy processing, how its global footprint...
Joe Renny, Head of Corporate Development at CatSci, returns to Trailblazers to explore whether a new Cold War is emerging around pharmaceutical innovation. He and Perry Rearick discuss China’s growing role in drug discovery, the push for scientific and supply chain...
Bob File joins the Trailblazers to discuss technology, digital transformation & AI, and how life sciences and clinical trials are being impacted. He reminds us that human beings in the loop are the most important feature of AI. Bob is also a former Major League...
New cell and gene therapy clinical breakthroughs & manufacturing innovations are emerging quickly in a field characterized by scientific acceleration. It is awfully difficult for CDMOs to effectively communicate their capabilities, let alone establish a new brand in...
Disappointing results have B2B solution providers questioning the effectiveness of traditional digital marketing, like email and organic website traffic. Vast amounts of time and resources are wasted trying to address the symptoms and there is little progress on...
The story of Catalent is one for the ages, an epic tale of growth and the establishment of what we now know as the modern pharmaceutical contract development and manufacturing organization. John Chiminski served as the CEO for fourteen extraordinary years and tells...
Claire Martell is Co-Founder, CEO and President of Murdock-Martell, a finance, accounting and human resources firm that works with some of the most innovative life sciences and technology startups. In this edition of the Trailblazers, she shares her insights into the...
Greg Ippolito, President & Creative Director at Ippolito Media Arts, IMA, is back in this episode of the Trailblazers. He speaks about a new type of silo that is appearing in B2B solution provider companies that results in fragmented marketing plans and has...
Rick Hancock, CEO, Argonaut Manufacturing Services; Tim Lowery, CEO, KBI Biopharma & President, JSR Life Sciences; & Tim Mitchell, CEO Sentry Biopharma Services join me for this edition of the Trailblazers to talk about the tri-partnership they have formed,...
An interview with Joseph Carleone, acclaimed business leader. Mr. Carleone has spent most of his life in executive leadership positions from companies in the defense industry to chemicals, pharmaceuticals, food and cosmetics. In those 45-plus years he experienced...
An interview with Susan Lynch-Smith, Head of Business Development, Douglas CDMO. Sue shares her 30 years of experience in B2B life sciences including the ever-evolving relationship between buyer and solution provider, the importance of empathy, account based...
It isn't easy to transform innovations into a sustainable commercial business, PTI has done it and continues to do so. In this discussion with Oliver Stauffer, their CEO, we discuss the importance of packaging which is the last defense in protecting life sciences...
Life Science Connect helps life science companies reach the right audiences, build credibility, stay visible during long buying cycles, and turn meaningful engagement into better commercial conversations.
Explore Life Science Connect’s audience data, communities, and solutions all in one place.
